M
Masaaki Nakayama
Researcher at Tohoku University
Publications - 245
Citations - 8900
Masaaki Nakayama is an academic researcher from Tohoku University. The author has contributed to research in topics: Peritoneal dialysis & Kidney disease. The author has an hindex of 40, co-authored 236 publications receiving 7811 citations. Previous affiliations of Masaaki Nakayama include Fukushima University & International University, Cambodia.
Papers
More filters
Journal ArticleDOI
Possible involvement of cross-linking advanced glycation endproducts in long-term CAPD peritoneal degeneration
Journal ArticleDOI
Tranexamic acid increases peritoneal ultrafiltration volume in patients on CAPD
TL;DR: It is suggested that TNA enhances UF volume in patients both with and without UF loss, and may be associated with suppression of the BK and/or tPA system, at least in patients with UF Loss.
Journal ArticleDOI
Home blood pressure level and decline in renal function among treated hypertensive patients: the J-HOME-Morning Study.
Kazuki Ishikura,Taku Obara,Masahiro Kikuya,Michihiro Satoh,Miki Hosaka,Hirohito Metoki,Hidekazu Nishigori,Nariyasu Mano,Masaaki Nakayama,Yutaka Imai,Takayoshi Ohkubo +10 more
TL;DR: Morning home BP might be useful for risk evaluation of decline in renal function even among treated hypertensive patients with normal renal function, and target levels of home BP control among treated hypertension patients need to be further investigated.
Journal ArticleDOI
The effect of angiotensin receptor blockade ARB on the regression of left ventricular hypertrophy in hemodialysis patients: comparison between patients with D allele and non-D allele ACE gene polymorphism.
Masaaki Nakayama,H. Nakano,Nobuo Tsuboi,Takeshi Kurosawa,Yoshinari Tsuruta,Yoshiko Iwasaki,Keitaro Yokoyama,Tatsuo Hosoya,Masafumi Fukagawa +8 more
TL;DR: It is indicated that ARB could insert a regression effect on LVH predominantly in patients with D allele ACE polymorphism, due partly to factor (s) independent of its anti-hypertensive effect.
Journal ArticleDOI
Correction of CAPD catheter displacement using alpha-replacement method.
TL;DR: The alpha-replacement method for a displaced CAPD catheter proved to be effective and safe, and required time was only 5–10 min in most successful cases.